These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22407982)

  • 21. IL-12 receptor. I. Characterization of the receptor on phytohemagglutinin-activated human lymphoblasts.
    Chizzonite R; Truitt T; Desai BB; Nunes P; Podlaski FJ; Stern AS; Gately MK
    J Immunol; 1992 May; 148(10):3117-24. PubMed ID: 1578138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors.
    Kawakami M; Kawakami K; Takahashi S; Abe M; Puri RK
    Cancer; 2004 Sep; 101(5):1036-42. PubMed ID: 15329913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional effect of the R110Q IL13 genetic variant alone and in combination with IL4RA genetic variants.
    Chen W; Ericksen MB; Levin LS; Khurana Hershey GK
    J Allergy Clin Immunol; 2004 Sep; 114(3):553-60. PubMed ID: 15356556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway.
    Kawakami K; Taguchi J; Murata T; Puri RK
    Blood; 2001 May; 97(9):2673-9. PubMed ID: 11313257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.
    Kioi M; Kawakami M; Shimamura T; Husain SR; Puri RK
    Cancer; 2006 Sep; 107(6):1407-18. PubMed ID: 16902988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of interleukin-13 and interleukin-4 to the interleukin (IL)-4/IL-13 receptor of human synovial fibroblasts.
    Lutz RA; Feng N; Moser R
    J Recept Signal Transduct Res; 1999; 19(1-4):181-90. PubMed ID: 10071757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of antitumor activity of an interleukin-13 (IL-13) receptor-targeted cytotoxin composed of IL-13 antagonist and Pseudomonas exotoxin.
    Kioi M; Kawakami K; Puri RK
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6231-8. PubMed ID: 15448012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous metalloprotease solubilizes IL-13 receptor alpha2 in airway epithelial cells.
    Matsumura M; Inoue H; Matsumoto T; Nakano T; Fukuyama S; Matsumoto K; Takayama K; Saito M; Kawakami K; Nakanishi Y
    Biochem Biophys Res Commun; 2007 Aug; 360(2):464-9. PubMed ID: 17603012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the interleukin-4 receptor complex in human corneal fibroblasts.
    Fukuda K; Fujitsu Y; Kumagai N; Nishida T
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):183-8. PubMed ID: 11773030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping mouse IL-13 binding regions using structure modeling, molecular docking, and high-density peptide microarray analysis.
    Madala SK; Dolan MA; Sharma D; Ramalingam TR; Wilson MS; Mentink-Kane MM; Masison DC; Wynn TA
    Proteins; 2011 Jan; 79(1):282-93. PubMed ID: 21064130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2.
    Popovic B; Breed J; Rees DG; Gardener MJ; Vinall LM; Kemp B; Spooner J; Keen J; Minter R; Uddin F; Colice G; Wilkinson T; Vaughan T; May RD
    J Mol Biol; 2017 Jan; 429(2):208-219. PubMed ID: 27956146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the extracellular region of the human interleukin-4 receptor alpha chain and interleukin-13 receptor alpha1 chain by a silkworm-baculovirus system.
    Honjo E; Shoyama Y; Tamada T; Shigematsu H; Hatanaka T; Kanaji S; Arima K; Ito Y; Izuhara K; Kuroki R
    Protein Expr Purif; 2008 Jul; 60(1):25-30. PubMed ID: 18467124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel 4-kb interleukin-13 receptor alpha mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor.
    Gauchat JF; Schlagenhauf E; Feng NP; Moser R; Yamage M; Jeannin P; Alouani S; Elson G; Notarangelo LD; Wells T; Eugster HP; Bonnefoy JY
    Eur J Immunol; 1997 Apr; 27(4):971-8. PubMed ID: 9130652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
    Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
    Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.
    Moritz RL; Ward LD; Tu GF; Fabri LJ; Ji H; Yasukawa K; Simpson RJ
    Growth Factors; 1999; 16(4):265-78. PubMed ID: 10427501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific inhibition of interleukin-13 activity by a recombinant human single-chain immunoglobulin domain directed against the IL-13 receptor alpha1 chain.
    Knackmuss S; Krause S; Engel K; Reusch U; Virchow JC; Mueller T; Kraich M; Little M; Luttmann W; Friedrich K
    Biol Chem; 2007 Mar; 388(3):325-30. PubMed ID: 17338640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-13 signal transduction in human monocytes: phosphorylation of receptor components, association with Jaks, and phosphorylation/activation of Stats.
    Roy B; Bhattacharjee A; Xu B; Ford D; Maizel AL; Cathcart MK
    J Leukoc Biol; 2002 Sep; 72(3):580-9. PubMed ID: 12223527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of action of interleukin-13 antagonist (IL-13E13K) in cells expressing various types of IL-4R.
    Kioi M; Kawakami K; Puri RK
    Cell Immunol; 2004 May; 229(1):41-51. PubMed ID: 15331327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative characterization of the intrinsic ligand-binding affinity of the interleukin 2 receptor beta chain and its modulation by the alpha chain and a second affinity-modulating element.
    Ringheim GE; Freimark BD; Robb RJ
    Lymphokine Cytokine Res; 1991 Jun; 10(3):219-24. PubMed ID: 1883916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allergy-driven alternative splicing of IL-13 receptor alpha2 yields distinct membrane and soluble forms.
    Tabata Y; Chen W; Warrier MR; Gibson AM; Daines MO; Hershey GK
    J Immunol; 2006 Dec; 177(11):7905-12. PubMed ID: 17114462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.